← All trials
NCT06568133
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2017
- Primary completion
- Jul 4, 2017
- Completion date
- Feb 7, 2018
- First posted
- Aug 23, 2024
- Last posted
- Aug 23, 2024
- Enrollment
- 57
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Korea United Pharm. Inc.Lead sponsor
- Chungnam National UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.